| 1 |
Partly verified |
Full text not readStored summary read |
N01 · Evidence conditionWhich acute-nausea question is addressed?Required |
The selected question is relief of acute nausea within 10 minutes, graded C. The positive registered trial and its small, ultra-short subjective endpoint are retained together. Actual vomiting and cause treatment are separate questions. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
Selected 10-minute nausea question, original grade and note versus separate vomiting |
Material needed: Original direct comparisons, arm-specific denominators, target effects, CIs and selected versus parent boundaries are needed. No new question, independence certification or subclaim score is created. This records needed materials; no new research was executed. |
| 2 |
Partly verified |
Full text not readStored summary read |
N02 · Evidence conditionWhat is Beadle's direct 10-minute result?Required |
The original 10-minute medians are 3 with alcohol versus 6 with saline, a difference of 3 (95% CI 2 to 4). These are reported values, not a new effect calculated by subtracting arm values. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
Original 10-minute NRS findings, difference, CI and comparison |
Material needed: Scale range, direction, baseline, estimation methods, the effect targeted by the CI and arm-specific analysis denominators are needed. Findings are not transferred to other times or scales. This records needed materials; no new research was executed. |
| 3 |
Partly verified |
Full text not readStored summary read |
N03 · Evidence conditionDo recruitment, completion and arm counts share an analysis denominator?Required |
The record retains 84 recruited, 80 completed, 37 alcohol and 43 saline. Analysis wording in the Korean original and completion wording in the English original are distinguished without further establishing endpoint-specific analysis stages. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
Beadle recruitment, completion, analysis and arm counts |
Material needed: Original flow, analysis populations, nausea, satisfaction and rescue denominators and missing-data handling are needed. No new attrition or event count is calculated from differences. This records needed materials; no new research was executed. |
| 4 |
Partly verified |
Full text not readStored summary read |
N04 · Evidence conditionIs MCID 1.5 the same as an externally validated important difference?Required |
April records MCID 1.5, MD -2.18/10 (95% CI -2.76 to -1.60) and moderate certainty. The parent account leaves an externally validated important difference uncertain; these levels are distinguished. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
Prespecified criteria, review effects and external clinical importance |
Material needed: MCID sources, prespecification, patient-important criteria, measurement tools, effect distributions and responder data are needed. This is not promoted into current official GRADE certification. This records needed materials; no new research was executed. |
| 5 |
Partly verified |
Full text not readStored summary read |
N05 · Evidence conditionIs satisfaction +2 a nausea or vomiting effect?Required |
Beadle's satisfaction +2 is retained as a reported result. A separate satisfaction scale and CI are unverified; this is not the same value as nausea NRS or cessation of actual vomiting. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
Satisfaction measures versus nausea NRS and vomiting events |
Material needed: Satisfaction tools, timing, denominators, between-group estimates, CIs and prespecified hierarchy are needed. This records needed materials; no new research was executed. |
| 6 |
Partly verified |
Full text not readStored summary read |
N06 · Evidence conditionWere rescue-antiemetic findings the same in every trial?Required |
Beadle records null rescue use, while Candemir records less rescue treatment. Favorable nausea findings do not establish reductions in all trials; rescue need, actual vomiting and cause treatment are distinguished. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
Rescue medication and treatment versus other endpoints |
Material needed: Rescue criteria, drugs, exposure, timing, denominators, between-group effects, CIs and concurrent care are needed. This records needed materials; no new research was executed. |
| 7 |
Partly verified |
Full text not readStored summary read |
N07 · Evidence conditionWhat are Candemir's repeated-time results?Required |
The record retains 118 in ITT, 115 completed, NRS at 2, 4 and 10 minutes, rescue treatment and an overall between-group effect from 2 minutes, P=.008. It is not copied as identical effects, CIs or P values at each time. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
NRS at 2, 4 and 10 minutes and the overall between-group analysis |
Material needed: Time-specific effects, CIs, denominators, repeated-measures models, multiple comparisons and prespecified hierarchy are needed. This records needed materials; no new research was executed. |
| 8 |
Partly verified |
Full text not readStored summary read |
N08 · Evidence conditionAre 10-minute NRS and 30-minute within-group VAS the same?Required |
The Korean account's 120-person, 3-arm trial records 30-minute within-group VAS reductions of 30mm with alcohol, 32mm with ondansetron plus alcohol and 9mm with ondansetron plus saline. This is distinguished from the 10-minute saline-controlled between-group NRS effect. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
NCT02760069's separate 3-arm, 30-minute comparison |
Material needed: Original 3-arm material, arm-specific allocation and analysis, interventions, concurrent drugs, timing, between-group VAS effects, CIs and prespecified plans are needed. No scale conversion or new between-group CI is created. This records needed materials; no new research was executed. |
| 9 |
Partly verified |
Full text not readStored summary read |
N09 · Evidence conditionWhat do the review's 2 RCTs and 195 participants represent?Required |
The original record retains 2 saline-controlled RCTs, 195 participants and a 10-minute MD of -2.18/10. Trial samples are not newly summed to certify this total, and the review is not added as a new independent RCT. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
April synthesis, included trials and extraction denominators |
Material needed: Included-trial identities, time- and scale-specific extraction denominators, overlap, meta-analysis methods, bias and certainty materials are needed. This records needed materials; no new research was executed. |
| 10 |
Partly verified |
Full text not readStored summary read |
N10 · Evidence conditionWere within-group changes distinguished from direct between-group results?Required |
Beadle's difference and CI and Candemir's overall between-group P value are distinguished as direct comparisons. The separate 120-person, 3-arm, 30-minute values are within-group changes and are not merged into the same effect. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
Study-specific target effects and analysis levels |
Material needed: Baseline adjustment, change and endpoint comparisons, models and original between-group estimates and CIs are needed. No new between-group effect is calculated by subtracting within-group values. This records needed materials; no new research was executed. |
| 11 |
Partly verified |
Full text not readStored summary read |
N11 · Evidence conditionWere registration and subjective-endpoint limitations retained together?Required |
The original note retains positive registered findings alongside small samples, a 10-minute subjective scale and blinding limitations. A registration number does not resolve all bias. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
Original prespecification narrative, small samples and ultra-short measurement |
Material needed: Original registration, changes, prespecified endpoints, analyses, allocation, measurement and missing-data material are needed. Selected C is not promoted into a new grade. This records needed materials; no new research was executed. |
| 12 |
Partly verified |
Full text not readStored summary read |
N12 · Evidence conditionDoes a brief nausea-score result establish less actual vomiting?Required |
The parent states that nausea over minutes does not mean vomiting stops. Its account of null vomiting in one supporting trial is retained; trial identity and event counts remain unverified. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
Subjective nausea versus separate vomiting-event evidence |
Material needed: Vomiting definitions, report identity, events versus people, timing, denominators, between-group effects and CIs are needed. Nausea effects are not converted into reduced vomiting. This records needed materials; no new research was executed. |
| 13 |
Partly verified |
Full text not readStored summary read |
N13 · Evidence conditionDoes 10-minute relief establish cause treatment or less clinical care?Required |
The parent distinguishes brief nausea relief while awaiting assessment from reduced underlying diagnosis, treatment or fluid needs. Its original statement that the latter are not demonstrated is retained. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
Underlying diagnosis, treatment, fluids and concurrent care boundaries |
Material needed: Direct studies and denominators for cause-specific diagnosis, treatment, care, fluids and important clinical outcomes are needed. No new administration, procedure or care guidance is created. This records needed materials; no new research was executed. |
| 14 |
Partly verified |
Full text not readStored summary read |
N14 · Evidence conditionDo short-term findings establish durability or recurrence effects?Required |
The principal endpoint is 10 minutes, with a separate 30-minute result. Persistence, recurrence and repeated-exposure effects after discharge are not established, and short-term material is not labeled long-term. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
A 10-minute endpoint versus long-term and recurrent nausea |
Material needed: Longer follow-up, recurrence, rescue, cause treatment, concurrent care and corresponding analysis denominators are needed. This records needed materials; no new research was executed. |
| 15 |
Partly verified |
Full text not readStored summary read |
N15 · Evidence conditionWhich emergency-department adults were studied?Required |
The parent scope concerns acute nausea in emergency-department adults. Recruitment, completion and arm counts from the representative trial do not replace full causes or eligibility criteria. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
Eligibility, causes and baseline severity in acute nausea |
Material needed: Cause-specific recruitment, baseline NRS, comorbidities, emergency conditions, exclusions and trial-specific recruitment methods are needed. Findings are not extended to other populations or settings. This records needed materials; no new research was executed. |
| 16 |
Partly verified |
Full text not readStored summary read |
N16 · Evidence conditionWhat are the formulation and route boundaries for the 70% pad?Required |
The original intervention is brief inhalation from a 70% isopropyl-alcohol pad. Concentration is not converted into inhaled quantity, frequency or exposure; ingestion and broad skin application are distinguished. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
Original formulation, concentration, exposure and intervention boundaries |
Material needed: Original products, manufacturing, pad volume, exposure criteria and comparability between arms are needed. No new procedure or administration method is created. This records needed materials; no new research was executed. |
| 17 |
Partly verified |
Full text not readStored summary read |
N17 · Evidence conditionAre saline-odor control and drug comparisons the same?Required |
Beadle's saline-odor control is distinguished from NCT02760069's 120-person, 3-arm comparison involving ondansetron. Controls and results are not treated as the same effect. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
Controls, concurrent drugs, rescue medication and target effects |
Material needed: Arm-specific interventions, concurrent antiemetics, allocation, rescue criteria, target effects and original between-group results are needed. This records needed materials; no new research was executed. |
| 18 |
Partly verified |
Full text not readStored summary read |
N18 · Evidence conditionWere recruitment, completion, ITT and endpoint denominators distinguished?Required |
Beadle's 84 recruited, 80 completed, 37 alcohol and 43 saline, and Candemir's 118 in ITT and 115 completed are retained. A separate 120-person, 3-arm trial and the review's 195 participants are different contexts. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
Trial flow and valid arm- and endpoint-specific denominators |
Material needed: Recruitment, allocation, completion, time-specific assessments, analysis, arm-specific missingness and ITT definitions are needed. No new differences or participant totals are calculated. This records needed materials; no new research was executed. |
| 19 |
Partly verified |
Full text not readStored summary read |
N19 · Evidence conditionWhat are odor-related blinding limitations?Required |
The account and bibliography retain incomplete blinding due to odor. The randomized-trial label does not establish adequate subjective assessment and blinding throughout. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
Allocation, concealment, subjective-score collection and expectations |
Material needed: Allocation, concealment, people blinded, blinding success, NRS collectors, procedures, losses and revealing cues are needed. No new official RoB2 judgment is made. This records needed materials; no new research was executed. |
| 20 |
Partly verified |
Full text not readStored summary read |
N20 · Evidence conditionDoes a registration number mean external registration was read?Required |
NCT02092441 appears in original evidence and bibliography, and NCT02760069 in the Korean account. Candemir's original registration is unverified. CRD42022299815 identifies April's review; external registration and plans were unread here. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
Trial registration, review registration and prespecification material |
Material needed: Each trial's and review's original registration, changes, protocol, analysis plans, prespecified endpoints and denominators must be distinguished. Numbers alone do not establish verified prespecification or identity. This records needed materials; no new research was executed. |
| 21 |
Partly verified |
Full text not readStored summary read |
N21 · Evidence conditionWere different company-involvement items distinguished?Required |
Beadle is reported as a military institutional study without manufacturer sponsorship; Candemir reports no COI with specific funding unverified; April reports academic research without manufacturer involvement. Detailed funding for the separate combined-drug comparison is unverified. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
Funding, product support, affiliations, analysis and publication roles |
Material needed: Original documents on financial and product support, company affiliations, design, analysis and publication roles are needed separately. One item does not establish absence of every form of involvement. This records needed materials; no new research was executed. |
| 22 |
Partly verified |
Full text not readStored summary read |
N22 · Evidence conditionWere reports, reviews and subquestions double-counted?Required |
Both subquestions share the parent's Beadle, Candemir and April reports and separate Korean comparison context. The review synthesizes included trials, and the Korean 120-person description is not a separate evidence or bibliography entry. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
Reports, original trials, cohorts and shared relationships |
Material needed: Included trials, time-specific analysis populations, reports and cohort identity tables are needed. Report slots, sheets and samples are not added as unique trials, participants or independent replications. This records needed materials; no new research was executed. |
| 23 |
Partly verified |
Full text not readStored summary read |
N23 · Evidence conditionWhat is the level of the original independent-replication wording?Required |
The parent's independent-replication wording and unverified funding, registration and prespecification are retained together. They are not promoted into current independence certification or a confirmed unique-trial total. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
Candemir support versus funding and prespecification gaps |
Material needed: Original registration, plans, institutions, recruitment, support and overlapping-report relationships are needed. Uncertain unique totals remain uncertain. This records needed materials; no new research was executed. |
| 24 |
Partly verified |
Full text not readStored summary read |
N24 · Evidence conditionWere differing parent Korean and English contexts retained?Required |
The Korean account contains NCT02760069's 30-minute within-group VAS; the English account contains a 10-minute meta-analysis of two placebo-controlled trials and 195 participants. They are not substituted for each other as translations of the same report, time or effect. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
Korean 30-minute, 3-arm findings versus English synthesis |
Material needed: Original trial and review result tables, denominators, times and effect comparisons are needed. Complete parent Korean and English accounts are preserved without new external comparison or correction. This records needed materials; no new research was executed. |
| 25 |
Partly verified |
Full text not readStored summary read |
N25 · Evidence conditionDoes stored-summary reading equal external-original reading?Required |
The complete stored parent summary was read. Historical verification and cross-check narratives are distinguished from actual reading here; external abstracts, full text, registration and plans remain unread. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
Report-specific summary, abstract, full-text, registration and plan status |
Material needed: Actual acquisition or review requires separate identity, access and reading-level records. A URL alone does not establish reading, successful access or completed content review. This records needed materials; no new research was executed. |
| 26 |
Partly verified |
Full text not readStored summary read |
N26 · Evidence conditionAre adverse-event collection, denominators and exposure known?Supplementary |
Parent safety cautions are preserved unchanged. April lists adverse events, but arm-specific event counts, collection methods, denominators and exposure quantities are unverified. Missing numbers are not converted into safety or absence of events. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
Harm events, collection, severity, exposure and discontinuation |
Material needed: Active collection, events versus affected people, severity, onset, exposure, arm-specific denominators, discontinuation, rescue and causality-assessment material are needed. This records needed materials; no new research was executed. |
| 27 |
Partly verified |
Full text not readStored summary read |
N27 · Evidence conditionCan repeated or long-term exposure and vulnerable groups be assessed?Supplementary |
The principal 10-minute and separate 30-minute results are not extended into safety verification for long-term or repeated exposure, pregnancy or respiratory vulnerability. Parent cautions are not turned into new procedure guidance. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
Brief observation versus long-term, rare harms and vulnerable populations |
Material needed: Long-term and repeated exposure, vulnerable-group eligibility, arm-specific harm follow-up, denominators and actual exposure material are needed. This records needed materials; no new research was executed. |
| 28 |
Partly verified |
Full text not readStored summary read |
N28 · Evidence conditionHow do selected C, separate D and parent C54 differ?Required |
Acute nausea is C and actual vomiting or cause treatment is D. Individual scores, status and axes are absent; parent C54, Caution and B/P/R1/I2/E+/B2/CX belong to the overall context. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
Selected and separate subclaim grades versus parent score, status and axes |
Material needed: Subclaim and parent records and application boundaries must be distinguished. Parent values do not overwrite subclaim D or create new scores, harm grades or independence certification. This records needed materials; no new research was executed. |
| 29 |
Partly verified |
Full text not readStored summary read |
N29 · Evidence conditionAre historical draft B and final C a new reassessment?Required |
The parent's draft B, final C, 54 points and cross-check record are historical. The grade was not reassessed in this production. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
Original grade-decision history versus current production |
Material needed: A requested verdict change requires preservation of complete originals, events, versions and reasons. This work retains original values. This records needed materials; no new research was executed. |
| 30 |
Partly verified |
Full text not readStored summary read |
N30 · Evidence conditionWere original dates, corrections and production times separated?Required |
The original date is 2026-09-07, corrections are an empty array and deliberation an empty string. The current production time does not become an evidence-verification date, and no absent correction is invented. |
This state links partial information and gaps in the preserved selected and parent accounts. External verification and clinical content review remain incomplete; it does not certify fulfilled conditions, efficacy, safety, prespecification or independence. |
Historical evidence date, empty corrections and deliberation versus new changes |
Material needed: Material additions, condition revisions, observation application and verdict changes must remain separate events, preserving previous originals. This records needed materials; no new research was executed. |